Reported 12 months ago
Following the release of Walgreens Boots Alliance's fiscal third-quarter earnings report, the stock price plummeted over 53% in 2024, with reduced guidance and store closures contributing to the decline. The company saw a rise in revenue but a significant drop in adjusted EPS. With plans to close a portion of its U.S. locations, reduce stake in VillageMD, and seek a new reimbursement system, investors need to consider the company's debt, cash flow issues, and valuation before deciding on investing in Walgreens.
Source: YAHOO